HSK44459 clinical trials
Also written HSK44459.
How each study uses HSK44459 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the HSK44459 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- HSK44459
- 6
Studies by the year they started
10 studies that test it; most in 2025 (6)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 0
Haisco Pharmaceutical Group Co., Ltd. (9) · Xizang Haisco Pharmaceutical Co., Ltd (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test HSK44459.
- Nov 2026A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque PsoriasisPhase 2 · Haisco Pharmaceutical Group Co., Ltd.
- Mar 2027Trial of HSK44459 Cream for the Management Plaque PsoriasisPhase 1/2 · Haisco Pharmaceutical Group Co., Ltd.
- Jul 2027A Long-term Study of HSK44459 Tablets in Participants With Bechet's DiseasePhase 2 · Haisco Pharmaceutical Group Co., Ltd.
Studies
Open first, then newest update. How each study uses HSK44459 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary FibrosisNot yet recruitingPhase 3Haisco Pharmaceutical Group Co., Ltd.NCT07519070Written as HSK44459
- Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary FibrosisNot yet recruitingPhase 3Haisco Pharmaceutical Group Co., Ltd.NCT07503587Written as HSK44459
- A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque PsoriasisNot yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07150988Written as HSK44459 dose level 1
- A Long-term Study of HSK44459 Tablets in Participants With Bechet's DiseaseNot yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07070739Written as HSK44459 tablets
- Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)Not yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT07019090Written as HSK44459
- Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's DiseaseNot yet recruitingPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT06902428Written as HSK44459
- Trial of HSK44459 Cream for the Management Plaque PsoriasisActive, not recruitingPhase 1/2Haisco Pharmaceutical Group Co., Ltd.NCT07623486Written as HSK44459 Cream
- Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary FibrosisCompletedPhase 2Haisco Pharmaceutical Group Co., Ltd.NCT06764862Written as HSK44459 dose 1
- A Study for HSK44459 in Participants With Atopic DermatitisActive, not recruitingPhase 2Xizang Haisco Pharmaceutical Co., LtdNCT06996912Written as HSK44459
- A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy SubjectsCompletedPhase 1Haisco Pharmaceutical Group Co., Ltd.NCT06858657Written as HSK44459